In the midst of a delta variant surge, a new study finds that giving a booster dose of the Johnson & Johnson shot six months after primary vaccination results in a nine-fold increase of a crucial antibody response, according to a company press release. Meanwhile, a prior study found that people vaccinated with the Johnson
Fox News Flash top headlines for July 22 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. An advisory panel to the Centers for Disease Control and Prevention (CDC) said the benefits of COVID-19 vaccines “far outweigh” potential risks amid an ongoing review of reports of a rare nerve disorder in
Over the course of the COVID-19 pandemic, the healthcare industry has undergone a digital transformation. Now, as vaccines become more readily available, and as cases continue to fall, the question on many healthcare leaders’ minds is: How can that innovation continue in a post-pandemic world? In a HIMSS21 Global Conference Digital Session set to air on Tuesday,
Johnson & Johnson remains “very confident” in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday. “We remain very confident and very hopeful that the benefit-risk profile will play out,” J&J Chief Financial Officer Joseph Wolk told CNBC. The comments came ahead of a decision
A pause on all US vaccinations with the Johnson & Johnson COVID shot will continue for at least another week after members of a government-convened expert panel said Wednesday they needed more time to assess its possible links to a clotting disorder. The Centers for Disease Control and Prevention (CDC) convened a meeting a day
Federal health officials called for a pause in the use of the Johnson & Johnson vaccine at federal sites starting today. This comes after a total of six women out of the roughly 7 million people who have been vaccinated so far developed a rare and severe blood clot issue. At this time, the FDA
Four million doses of the latest COVID-19 vaccine to get US approval will be delivered across the country as early as Tuesday, a senior administration official said. The United States on Saturday authorized Johnson & Johnson’s COVID vaccine for emergency use, boosting President Joe Biden’s plan to battle the outbreak that has killed more than
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok